comMitment
100 %
Excellence
leadership
25+
Year Experience
BENELUX SERVICED
3
Countries
Succesful
120+
Submissions
Real world data
Improving Access, Powered by Real World
Data
We design and implement Belgium-specific real world data pilots, identifying the right registries and clinical partners to generate high-quality insights. By integrating meaningful patient-reported outcomes, we support you in building a stronger, data-driven value proposition that reflects the patient impact.
the foundation
Meaningful real world data begins with the right insights, the right partners, robust data and the patient's voice.
01
Support the transitioning
We support you in the transitioning of RWD into a strategic asset—supporting sustained access, reinforcing competitive positioning, and strengthening trust among the different partners (company, healthcare professionals, patients and payers). Equally important is the timely translation of real‑world insights into accurate, strategically aligned responses for payers.
03
maintain reimbursement
Securing reimbursement is only the beginning. Long‑term access requires a structured, data‑driven approach: generating the right evidence through appropriate data sources and trusted partners to address residual clinical and budgetary uncertainties.
02
Create a coherent and
convincing story
We translate RWD into a clear, locally grounded value narrative by integrating epidemiology, real-world clinical practice and the patient journey. This enables optimal product positioning and supports your transition from product supplier to trusted healthcare partner—delivering value for patients, clinicians, and payers.
From Data to Sustained Access
We turn real-world data into a strategic asset that supports sustained access and strengthens trust among all partners.
our three pillars
Comprehensive Access Solutions Services
How We Service our cutomers We facilitate a range of early access mechanisms tailored to bring innovation earlier to patients in Belgium.
01
NAMED PATIENT PROGRAM
Facilitating access for individual patients and physicians to medicines that are approved in other countries but not yet in Belgium.
02
Compassionate Use & Medical Need Program
We specialise in designing and implementing compassionate use and medical need programs, compliant with the requirements of the regulatory authorities. This allows rapid and controlled access to innovative therapies prior to reimbursement.
03
Early & Fast Access Program
We are fully engaged with the Early & Fast Access programs, overseen by the CATT/CAIT to bring transformative treatments faster to patients in need, while generating real-world medical and safety data.